Protection From Influenza by Intramuscular Gene Vector Delivery of a Broadly Neutralizing Nanobody Does Not Depend on Antibody Dependent Cellular Cytotoxicity

Cross-subtype neutralizing single domain antibodies against influenza present new opportunities for immunoprophylaxis and pandemic preparedness. Their simple modular structure and single open reading frame format are highly amenable to gene therapy-mediated delivery. We have previously described R1a...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Joanne Marie M. Del Rosario, Matthew Smith, Kam Zaki, Paul Risley, Nigel Temperton, Othmar G. Engelhardt, Mary Collins, Yasuhiro Takeuchi, Simon E. Hufton
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2020-05-01
Sarja:Frontiers in Immunology
Aiheet:
influenza
vaccine
adeno associated viral vectors
immunoprophylaxis
immunotherapy
nanobody
Linkit:https://www.frontiersin.org/article/10.3389/fimmu.2020.00627/full
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia